BB Biotech AG
BION
Rank in Stocks
#4507
BB Biotech AG is an investment fund overseen by Bellevue Asset Management AG.... BB Biotech AG is an investment fund overseen by Bellevue Asset Management AG. This fund allocates capital to publicly traded companies worldwide, with a primary focus on firms pioneering modern biotechnology, specifically in the development of medications and diagnostic tools. The construction of its investment portfolio is guided by a fundamental analysis approach. Established on November 9, 1993, BB Biotech AG is headquartered in Switzerland.
Share Price
$61.40
Last synced: 2026-10-21
Market Cap
$3.39B
Change (1 day)
-5.95%
Change (1 year)
25.48%
Country
CH
Trade BB Biotech AG (BION)
Category
Financial Services
Revenue for BB Biotech AG (BION)
Revenue in Oct 2026 TTM: 0
According to BB Biotech AG latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for BB Biotech AG from 2026 to 2026
Revenue at the end of each year
| Year | Revenue | Change |
|---|---|---|
| Not enough data for the provided dates. | ||
Revenue for similar companies or competitors
| Company | Revenue | Revenue Difference | Country |
|---|---|---|---|
| $28.54B | - |
US
|
|
| - | - |
SE
|
|
| $16.04B | - |
US
|
|
| $21.06B | - |
US
|
|
| $5.40B | - |
US
|
